Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Allergan, Inc.    AGN   US0184901025

ALLERGAN, INC. (AGN)

30
Delayed Quote. Delayed Nyse - 09/15 04:01:27 pm
168.56 USD   -0.41%
8h ago ALLERGAN : Pershing Square Submits Additional Special Meeting Requests
13h ago Ackman's Pershing Square plans $2 billion Amsterdam fund listing
3d agoDJU.S. HOT STOCKS : Hot Stocks to Watch
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Latest news on ALLERGAN, INC.
8h ago ALLERGAN : Pershing Square Submits Additional Special Meeting Requests
13h ago Ackman's Pershing Square plans $2 billion Amsterdam fund listing
3d agoDJU.S. HOT STOCKS : Hot Stocks to Watch
3d ago ALLERGAN : Pershing Square Submits Additional Special Meeting Requests Represent..
4d ago ALLERGAN : Comments on Pershing Square's Delivery of Additional Requests from St..
4d ago ALLERGAN : Comments on Pershing Square's Delivery of Additional Requests from St..
4d ago ALLERGAN : Assigned Patent
5d ago ALLERGAN : Researchers Submit Patent Application, "Implantable Materials", for A..
5d ago ALLERGAN : Patent Issued for Directionless (Orientation Independent) Needle Inje..
5d ago ALLERGAN : Bill Ackman Can Start Writing His Victory Speech (Maybe)
5d ago ALLERGAN : Announces OZURDEX® dexamethasone 700 mcg intravitreal implant in appl..
6d ago ALLERGAN : Bill Ackman Thought Allergan Directors Would’ve Accepted The Fa..
6d ago WILLIAM ACKMAN : Ackman urges Allergan board to 'wake up' on Valeant talks
09/05 TSX steady as financials-led retreat offsets resource gains
09/05 ALLERGAN : Pershing Square Submits Requisite Requests from Allergan Shareholders..
09/04 ALLERGAN : to Request California Federal Court Block Valeant and Pershing Square..
09/04 ALLERGAN : Provides Update on Written Requests from Pershing Square Regarding Sp..
09/04 ALLERGAN : Patent Issued for N-(Imidazolidin-2-Ylidene)quinoline Derivatives as ..
09/04 ALLERGAN : Patent Application Titled "Sustained Drug Delivery Implant" Published..
09/04 ALLERGAN : "Sustained Drug Delivery Implant" in Patent Application Approval Proc..
09/04 ALLERGAN : Patent Application Titled "Pharmaceutical Compositions Comprising 4-B..
09/04 ALLERGAN : Assigned Patent
09/03 ALLERGAN : Files Answer in Federal Court Responding to Valeant and Pershing Squa..
09/02 ALLERGAN : U.S. court revives Botox-linked shareholder suit against Allergan
09/02 ALLERGAN : Files Answer in Federal Court Responding to Valeant and Pershing Squa..
09/02 ALLERGAN : Files Answer in Federal Court Responding to Valeant and Pershing Squa..
09/02 ALLERGAN : Announces OZURDEX® (dexamethasone 700 mcg intravitreal implant in app..
08/28 ALLERGAN : "Modular Injection System and Method for Diluting an Injectable Fluid..
08/28 ALLERGAN : Assigned Patent
08/28 ALLERGAN : Maryland Laser Skin and Vein Receives Diamond Status From Allergan
08/28 ALLERGAN : "Cross-Linked Hyaluronic Acid and Collagen and Uses Thereof" in Paten..
08/27 WILLIAM ACKMAN : Valeant, Ackman get October 6 trial over Allergan special meeti..
08/27 ALLERGAN : Taps Jim Hindman as CFO
08/26 ALLERGAN : Facing shareholder demands, Allergan calls special meeting for Decemb..
08/26 ALLERGAN : to Request California Federal Court Block Valeant and Pershing Square..
08/26 ALLERGAN : Eyes INR10bn Revenues By Fiscal 2018 In India
08/26 ALLERGAN : Latisse.md Announces 5.5 Million Latisse Bottles Sold
08/26 ALLERGAN : EYES Rs1,000 CRORE REVENUE
08/23 ALLERGAN : reviews meeting requests in takeover bid
08/22 WILLIAM ACKMAN : Ackman, other shareholders ask Allergan to call special meeting
08/22 ALLERGAN : Receives Written Requests from Pershing Square Regarding Special Meet..
08/22 ALLERGAN : Pershing Square Submits Requisite Requests from Allergan Shareholders..
08/22 ALLERGAN : Beauty School is In Session--Create a No-Makeup, Makeup Look
08/22 ALLERGAN : Nearly Half of Women in New Survey Reveal that Their Current Treatmen..
08/22 ALLERGAN : Valeant, Ackman to submit Allergan special meeting request-CNBC
08/22 ALLERGAN : Other Events (form 8-K)
08/21 ALLERGAN : Federal court denies Allergan bid to speed insider trading suit
08/21 ALLERGAN : Names Jim Hindman as CFO
08/21 ALLERGAN : Taps Jim Hindman as CFO
08/21 ALLERGAN : Secures 2nd FTC Request Regarding Valeant's Unsolicited Acquisition P..
08/21 ALLERGAN : to Acquire LiRIS Program from Taris Biomedical
08/20 ALLERGAN : Patent Issued for Implantable Access Port with Mesh Attachment Rivets
08/20 ALLERGAN : Receives Second Request from Federal Trade Commission Regarding Valea..
08/20 ALLERGAN : Researchers Submit Patent Application, "Topical Treatment for Chemoth..
08/20 ALLERGAN : Patent Issued for Surgical Methods for Breast Reconstruction Or Augme..
08/20 ALLERGAN : Patent Issued for Injection Device for Soft-Tissue Augmentation Fille..
08/20 ALLERGAN : seeks deal with Salix
08/19 Allergan seeks deal with Salix to fend off Valeant - WSJ
08/19 ALLERGAN : Names Jim Hindman Chief Financial Officer
08/19 ALLERGAN : to Purchase LiRIS Program from Taris Biomedical
08/18 ALLERGAN : names Hindman chief financial officer
08/18 ALLERGAN : Change in Directors or Principal Officers, Financial Statements and E..
08/18 ALLERGAN : Names Jim Hindman Chief Financial Officer
08/17 ALLERGAN : R&D Innovations Secures 3 Nominations at the U.S. Prix Galien Awards
08/15 ALLERGAN : Gets 2nd FTC Request Regarding Valeant's Unsolicited Acquisition Prop..
08/14 ALLERGAN : Top hedge funds flocked to Allergan amid bid backed by Ackman
08/14 WILLIAM ACKMAN : Top hedge funds flocked to Allergan amid bid backed by Ackman
08/14 Pershing Square sues U.S. over Fannie Mae, Freddie Mac
08/14DJJOHN PAULSON : Paulson & Co. Opens Positions in Covidien, DirecTV and Allergan
08/14 WILLIAM ACKMAN : SEC reviewing Valeant, Ackman's hostile Allergan bid
08/14DJPershing Square Drops Stakes in Beam, Apartment Investment, Home Properties
08/14DJU.S. HOT STOCKS : Hot Stocks to Watch
08/13 ALLERGAN : Patent Issued for Anatomical Recognition and Dimensional Analysis of ..
08/13 ALLERGAN : Patent Application Titled "Ophthalmic Suspension for Ocular Use" Publ..
08/13DJALLERGAN : Acquires Taris Holdings' Lead Program
1  2  3  4  5  6  7  8  9  10Next
Advertisement
Chart
Duration : Period :
Allergan, Inc. Technical Analysis Chart | AGN | US0184901025 | 4-Traders
Income Statement Evolution
Allergan, Inc. : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF